CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.84B, above the global median of $1.15B
- FinancialsLow earnings quality
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.20%
Annual Rate
CNY 0.06Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
May 14, 2026
The reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
12.38BCNY1.84B · vs all stocks (USD)
Trailing P/E
124.79xRevenue (TTM)
1.00BCNY149.43M · vs all stocks (USD)
Profit Margin
9.79%Beta
0.6490xvs all stocks
52-Week Change
-27.40%vs all stocks
Forward Annual Dividend Yield
0.20%vs all stocks
Market Capitalization
12.38BCNY1.84B · vs all stocks (USD)
Enterprise Value
12.80BCNY1.90B · vs all stocks (USD)
Trailing P/E
124.79xForward P/E
-149.75xPrice to Sales (TTM)
13.20xPrice to Book (MRQ)
7.50xEnterprise to Revenue
12.73xEnterprise to EBITDA
62.34xGross Margin
85.80%Profit Margin
9.79%Operating Margin
16.00%Return on Assets (TTM)
2.13%Return on Equity (TTM)
4.75%Revenue (TTM)
1.00BCNY149.43M · vs all stocks (USD)
Revenue per Share (TTM)
2.44CNYUpdated Aug 21, 2026Quarterly Revenue Growth
58.40%Gross Profit (TTM)
874.39MCNY130.03M · vs all stocks (USD)
EBITDA (TTM)
158.74MCNY23.61M · vs all stocks (USD)
Net Income (TTM)
98.39MCNY14.63M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
45.36%Operating Cash Flow (TTM)
101.33MCNY15.07M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
53.81MCNY8.00M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0600CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
0.20%vs all stocks
Trailing Annual Dividend Rate
0.00CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
910.06MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
117.23MCNYFY2025 · Dec 31, 2025Gross Profit
792.83MCNYFY2025 · Dec 31, 2025Operating Income
99.64MCNY14.82M · vs all stocks (USD)
Pre-tax Income
50.05MCNYFY2025 · Dec 31, 2025Income Tax Expense
-906.71KCNYFY2025 · Dec 31, 2025Net Income
50.96MCNYFY2025 · Dec 31, 2025EBIT
85.75MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
158.74MCNYFY2025 · Dec 31, 2025Research & Development
221.62MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
262.28MCNYFY2025 · Dec 31, 2025Other Operating Expenses
16.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
17.04MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
35.70MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
50.96MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-101.84MCNYFY2025 · Dec 31, 2025Free Cash Flow
-280.43MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
228.68MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
50.96MCNYFY2025 · Dec 31, 2025Other Non-cash Items
25.63MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-160.14MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.29MCNYFY2025 · Dec 31, 2025Capital Expenditures
-178.59MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.71BCNYFY2025 · Dec 31, 2025Sale of Investments
1.67BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-217.62MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
491.90MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-310.94MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-31.74MCNYFY2025 · Dec 31, 2025Other Financing Charges
-21.62MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
127.60MCNYFY2025 · Dec 31, 2025Shares Outstanding
442.94MSharesUpdated Aug 21, 2026Float Shares
315.48MSharesUpdated Aug 21, 2026% Held by Insiders
25.89%vs all stocks
% Held by Institutions
6.38%vs all stocks
Total Cash (MRQ)
1.51BCNY225.19M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.42CNYUpdated Aug 21, 2026Total Debt (MRQ)
1.54BCNY229.55M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5972xCurrent Ratio (MRQ)
2.56xBook Value per Share (MRQ)
3.99CNYUpdated Aug 21, 2026Total Assets
3.65BCNY542.87M · vs all stocks (USD)
Total Current Assets
1.18BCNYFY2025 · Dec 31, 2025Total Liabilities
2.02BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.47BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.18BCNYFY2025 · Dec 31, 2025Total Current Liabilities
843.90MCNYFY2025 · Dec 31, 2025Cash
347.57MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.33KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
347.57MCNYFY2025 · Dec 31, 2025Other Short-term Investments
295.30MCNYFY2025 · Dec 31, 2025Accounts Receivable
286.99MCNYFY2025 · Dec 31, 2025Inventory
57.68MCNYFY2025 · Dec 31, 2025Accounts Payable
3.78MCNYFY2025 · Dec 31, 2025Short-term Debt
507.44MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.55MCNYFY2025 · Dec 31, 2025Long-term Debt
1.04BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
162.88KCNYFY2025 · Dec 31, 2025Common Stock (Book)
407.81MCNYFY2025 · Dec 31, 2025Retained Earnings
45.76MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.63BCNY241.78M · vs all stocks (USD)
Treasury Stock
15.00MCNYFY2025 · Dec 31, 202552-Week Low
23.41CNYUpdated Aug 21, 202652-Week High
39.69CNYUpdated Aug 21, 202652-Week Change
-27.40%vs all stocks
Beta
0.6490xvs all stocks
50-Day MA
27.66CNYUpdated Aug 21, 2026200-Day MA
29.50CNYUpdated Aug 21, 2026Avg 10-Day Volume
18.09MSharesUpdated Aug 21, 2026Avg 30-Day Volume
16.86MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.2400CNYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.58Receivables vs revenue divergence: 3.55
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -1.33
Altman Z-Score 4.12: safe zoneNotable
Altman Z-Score: 4.12
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.84B, above the global median of $1.15BNotable
Market cap (USD): 1,841,719,574.085Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Staidson (Beijing) Biopharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shenzhen Edge Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Novocure Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
OneSource Specialty Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Idorsia Ltd
Tier 1ProductionApproval-Gated PipelineRuleRisk
Ascletis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Cohance Lifesciences Limited
Tier 1ProductionApproval-Gated PipelineRule
Mirxes Holding Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
D&D Pharmatech Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk